Inventor
GRUSKIN ELLIOTT A
US31 patents
⚠️ This page may combine multiple inventors who share the name “GRUSKIN ELLIOTT A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNITED STATES SURGICAL CORP
11 patentsUS5578662ANov 26, 1996
Bioabsorbable branched polymers containing units derived from dioxanone and medical/surgical devices manufactured therefrom
UNITED STATES SURGICAL CORP191 citations99
US5505952AApr 9, 1996
Modified synthetic cross-linked amino acid polymers and medical devices formed therefrom
UNITED STATES SURGICAL CORP116 citations98
US6387363B1May 14, 2002
Biocompatible medical devices
UNITED STATES SURGICAL CORP69 citations96
US5534288AJul 9, 1996
Infection-resistant surgical devices and methods of making them
UNITED STATES SURGICAL CORP117 citations96
US5502042AMar 26, 1996
Methods and compositions for treating wounds
UNITED STATES SURGICAL CORP91 citations96
US6410519B1Jun 25, 2002
Scar reduction
UNITED STATES SURGICAL CORP59 citations95
US6207767B1Mar 27, 2001
Bioabsorbable branched polymer containing units derived from dioxanone and medical/surgical devices manufactured therefrom
UNITED STATES SURGICAL CORP43 citations92
US5480963AJan 2, 1996
Absorbable copolymers derived from tricarboxylic acids and surgical articles made therefrom
UNITED STATES SURGICAL CORP39 citations92
US6756518B2Jun 29, 2004
Scar reduction
UNITED STATES SURGICAL CORP43 citations91
US6927287B1Aug 9, 2005
Nucleic acid encoding extracellular matrix protein or fragment thereof
UNITED STATES SURGICAL CORP3 citations61
US6958223B2Oct 25, 2005
Methods for producing extracellular matrix proteins
UNITED STATES SURGICAL CORP0 citations50
ACORDA THERAPEUTICS INC
8 patentsUS11141467B2Oct 12, 2021
Methods of reducing extravasation of inflammatory cells
ACORDA THERAPEUTICS INC2 citations71
US7968089B2Jun 28, 2011
Proteoglycan degrading mutants for the treatment of CNS
ACORDA THERAPEUTICS INC2 citations60
US7959914B2Jun 14, 2011
Methods of reducing extravasation of inflammatory cells
ACORDA THERAPEUTICS INC2 citations60
US9839679B2Dec 12, 2017
Methods of reducing extravasation of inflammatory cells
ACORDA THERAPEUTICS INC0 citations50
US9528102B2Dec 27, 2016
Proteoglycan degrading mutants for treatment of CNS
ACORDA THERAPEUTICS INC0 citations49
US7429375B2Sep 30, 2008
Proteoglycan degrading mutants for the treatment of CNS
ACORDA THERAPEUTICS INC0 citations49
US9956273B2May 1, 2018
Compositions and methods for promoting neuronal outgrowth
ACORDA THERAPEUTICS INC0 citations48
US9468671B2Oct 18, 2016
Compositions and methods for promoting neuronal outgrowth
ACORDA THERAPEUTICS INC0 citations48
GRUSKIN ELLIOTT A
5 patentsUS11240977B2Feb 8, 2022
Compact photobioreactor with built-in lights
GRUSKIN ELLIOTT A5 citations72
US8183350B2May 22, 2012
Compositions and methods for promoting neuronal outgrowth
GRUSKIN ELLIOTT A4 citations68
US8679481B2Mar 25, 2014
Methods of reducing extravasation of inflammatory cells
GRUSKIN ELLIOTT A3 citations60
US8906363B2Dec 9, 2014
Fusion proteins for the treatment of CNS
GRUSKIN ELLIOTT A1 citations57
US8785606B2Jul 22, 2014
Compositions and methods for promoting neuronal outgrowth
GRUSKIN ELLIOTT A1 citations57